Annual EBIT:
-$3.08M+$64.44M(+95.43%)Summary
- As of today, SPRY annual earnings before interest & taxes is -$3.08 million, with the most recent change of +$64.44 million (+95.43%) on December 31, 2024.
- During the last 3 years, SPRY annual EBIT has risen by +$16.37 million (+84.15%).
- SPRY annual EBIT is now at all-time high.
Performance
SPRY EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBIT:
-$53.19M-$5.58M(-11.72%)Summary
- As of today, SPRY quarterly earnings before interest & taxes is -$53.19 million, with the most recent change of -$5.58 million (-11.72%) on September 30, 2025.
- Over the past year, SPRY quarterly EBIT has dropped by -$31.44 million (-144.58%).
- SPRY quarterly EBIT is now -212.70% below its all-time high of $47.20 million, reached on December 31, 2024.
Performance
SPRY Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
-$90.79M-$31.44M(-52.99%)Summary
- As of today, SPRY TTM earnings before interest & taxes is -$90.79 million, with the most recent change of -$31.44 million (-52.99%) on September 30, 2025.
- Over the past year, SPRY TTM EBIT has dropped by -$30.28 million (-50.04%).
- SPRY TTM EBIT is now -2844.73% below its all-time high of -$3.08 million, reached on December 31, 2024.
Performance
SPRY TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
SPRY EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +95.4% | -144.6% | -50.0% |
| 3Y3 Years | +84.2% | -702.3% | -108.3% |
| 5Y5 Years | +87.2% | -306.0% | -266.0% |
SPRY EBIT Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +95.4% | -212.7% | at low | -2844.7% | at low |
| 5Y | 5-Year | at high | +95.4% | -212.7% | at low | -2844.7% | at low |
| All-Time | All-Time | at high | +95.4% | -212.7% | at low | -2844.7% | at low |
SPRY EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | -$53.19M(-11.7%) | -$90.79M(-53.0%) |
| Jun 2025 | - | -$47.61M(-28.1%) | -$59.34M(-119.2%) |
| Mar 2025 | - | -$37.18M(-178.8%) | -$27.07M(-778.0%) |
| Dec 2024 | -$3.08M(+95.4%) | $47.20M(+317.0%) | -$3.08M(+94.9%) |
| Sep 2024 | - | -$21.75M(-41.8%) | -$60.51M(-6.6%) |
| Jun 2024 | - | -$15.34M(-16.3%) | -$56.74M(+8.5%) |
| Mar 2024 | - | -$13.19M(-29.0%) | -$62.00M(+8.2%) |
| Dec 2023 | -$67.52M(-90.1%) | -$10.23M(+43.1%) | -$67.52M(-17.8%) |
| Sep 2023 | - | -$17.98M(+12.7%) | -$57.29M(-24.7%) |
| Jun 2023 | - | -$20.60M(-10.1%) | -$45.95M(-45.0%) |
| Mar 2023 | - | -$18.71M(-182.2%) | -$31.69M(+27.3%) |
| Dec 2022 | -$35.52M | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | -$6.63M(-4.5%) | -$43.58M(+26.9%) |
| Jun 2022 | - | -$6.34M(+10.6%) | -$59.63M(+23.4%) |
| Mar 2022 | - | -$7.10M(+69.8%) | -$77.80M(+13.2%) |
| Dec 2021 | -$19.45M(+40.9%) | - | - |
| Dec 2021 | - | -$23.51M(-3.6%) | -$89.58M(-13.1%) |
| Sep 2021 | - | -$22.68M(+7.5%) | -$79.18M(-40.1%) |
| Jun 2021 | - | -$24.51M(-29.8%) | -$56.50M(-46.9%) |
| Mar 2021 | - | -$18.89M(-44.1%) | -$38.45M(-55.0%) |
| Dec 2020 | -$32.92M(-36.8%) | -$13.10M(-102.7%) | -$24.81M(-33.1%) |
| Jun 2020 | - | -$6.46M(-23.3%) | -$18.64M(-53.1%) |
| Mar 2020 | - | -$5.24M(+24.4%) | -$12.17M(-75.6%) |
| Dec 2019 | -$24.07M(-31.4%) | -$6.93M | -$6.93M |
| Dec 2018 | -$18.32M | - | - |
FAQ
- What is ARS Pharmaceuticals, Inc. annual earnings before interest & taxes?
- What is the all-time high annual EBIT for ARS Pharmaceuticals, Inc.?
- What is ARS Pharmaceuticals, Inc. annual EBIT year-on-year change?
- What is ARS Pharmaceuticals, Inc. quarterly earnings before interest & taxes?
- What is the all-time high quarterly EBIT for ARS Pharmaceuticals, Inc.?
- What is ARS Pharmaceuticals, Inc. quarterly EBIT year-on-year change?
- What is ARS Pharmaceuticals, Inc. TTM earnings before interest & taxes?
- What is the all-time high TTM EBIT for ARS Pharmaceuticals, Inc.?
- What is ARS Pharmaceuticals, Inc. TTM EBIT year-on-year change?
What is ARS Pharmaceuticals, Inc. annual earnings before interest & taxes?
The current annual EBIT of SPRY is -$3.08M
What is the all-time high annual EBIT for ARS Pharmaceuticals, Inc.?
ARS Pharmaceuticals, Inc. all-time high annual earnings before interest & taxes is -$3.08M
What is ARS Pharmaceuticals, Inc. annual EBIT year-on-year change?
Over the past year, SPRY annual earnings before interest & taxes has changed by +$64.44M (+95.43%)
What is ARS Pharmaceuticals, Inc. quarterly earnings before interest & taxes?
The current quarterly EBIT of SPRY is -$53.19M
What is the all-time high quarterly EBIT for ARS Pharmaceuticals, Inc.?
ARS Pharmaceuticals, Inc. all-time high quarterly earnings before interest & taxes is $47.20M
What is ARS Pharmaceuticals, Inc. quarterly EBIT year-on-year change?
Over the past year, SPRY quarterly earnings before interest & taxes has changed by -$31.44M (-144.58%)
What is ARS Pharmaceuticals, Inc. TTM earnings before interest & taxes?
The current TTM EBIT of SPRY is -$90.79M
What is the all-time high TTM EBIT for ARS Pharmaceuticals, Inc.?
ARS Pharmaceuticals, Inc. all-time high TTM earnings before interest & taxes is -$3.08M
What is ARS Pharmaceuticals, Inc. TTM EBIT year-on-year change?
Over the past year, SPRY TTM earnings before interest & taxes has changed by -$30.28M (-50.04%)